Literature DB >> 28034970

Cardiovascular Risk Factors in Cluster Headache.

S Santos Lasaosa1, E Bellosta Diago1, J Navarro Calzada2, A Velázquez Benito1.   

Abstract

Background: Patients with cluster headache tend to have a dysregulation of systemic blood pressure such as increased blood pressure variability and decreased nocturnal dipping. This pattern of nocturnal nondipping is associated with end-organ damage and increased risk of cardiovascular disease. Objective: To determine if cluster headache is associated with a higher risk of cardiovascular disease.
Methods: Cross-sectional study of 33 cluster headache patients without evidence of cardiovascular disease and 30 age- and gender-matched healthy controls. Ambulatory blood pressure monitoring was performed in all subjects. We evaluate anthropometric, hematologic, and structural parameters (carotid intima-media thickness and ankle-brachial index).
Results: Of the 33 cluster headache patients, 16 (48.5%) were nondippers, a higher percentage than expected. Most of the cluster headache patients (69.7%) also presented a pathological ankle-brachial index. In terms of the carotid intima-media thickness values, 58.3% of the patients were in the 75th percentile, 25% were in the 90th percentile, and 20% were in the 95th percentile. In the control group, only five of the 30 subjects (16.7%) had a nondipper pattern ( P  =   0.004), with 4.54% in the 90th and 95th percentiles ( P  =   0.012 and 0.015). Conclusions: Compared with healthy controls, patients with cluster headache presented a high incidence (48.5%) of nondipper pattern, pathological ankle-brachial index (69.7%), and intima-media thickness values above the 75th percentile. These findings support the hypothesis that patients with cluster headache present increased risk of cardiovascular disease.
© 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Ankle-Braquial Index; Blood Pressure Dip; Cardiovascular Disease; Cluster Headache; Intima-Media Thickness; Vascular Risk Factor

Mesh:

Year:  2017        PMID: 28034970     DOI: 10.1093/pm/pnw305

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  2 in total

Review 1.  The potential of lasmiditan in migraine.

Authors:  Jasper Mecklenburg; Bianca Raffaelli; Lars Neeb; Margarita Sanchez Del Rio; Uwe Reuter
Journal:  Ther Adv Neurol Disord       Date:  2020-10-21       Impact factor: 6.570

Review 2.  Drug Treatment of Cluster Headache.

Authors:  Hans Christoph Diener; Arne May
Journal:  Drugs       Date:  2021-12-17       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.